Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)
Status:
Withdrawn
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Given the strong inhibition of SCH 527123 on neutrophil migration to sites of inflammation,
there is a theoretical reason for its use in patients with severe asthma where neutrophils
are thought to play a significant role in the pathophysiology of the disease.